Literature DB >> 7512793

Aberrant production of interleukin-8 and thrombospondin-1 by psoriatic keratinocytes mediates angiogenesis.

B J Nickoloff1, R S Mitra, J Varani, V M Dixit, P J Polverini.   

Abstract

Psoriasis is a common inherited skin disease that is characterized by hyperproliferation of epidermal keratinocytes and excessive dermal angiogenesis. A growing body of evidence supports a key pathogenetic role for activated keratinocytes in the angiogenic response that accompanies psoriasis. We investigated the role of psoriatic epidermis in the aberrant expression of angiogenesis by examining the ability of pure populations of multipassaged keratinocytes obtained from the skin of normal individuals and psoriatic patients to induce angiogenesis in vivo in the rat corneal bioassay and endothelial cell chemotaxis in vitro. Media conditioned by keratinocytes from psoriatic patients, including both symptomless skin and psoriatic plaques, induced vigorous angiogenic responses in over 90% of corneas tested and potently stimulated directional migration of capillary endothelial cells in vitro. In contrast, conditioned medium from normal keratinocyte cultures was weakly positive in less than 10% of corneas assayed and failed to stimulate endothelial cell chemotaxis. Furthermore, keratinocytes from psoriatic skin exhibited a 10- to 20-fold increase in interleukin-8 production and a seven-fold reduction in thrombospondin-1 production. The angiogenic activity present in keratinocyte-conditioned media from psoriatic patients was suppressed by adding either highly purified thrombospondin-1 (125 ng) or following the addition of either normal keratinocyte-conditioned media or neutralizing interleukin-8 antibody. We conclude that psoriatic keratinocytes are phenotypically different from normal keratinocytes with respect to their angiogenic capacity and that this aberrant phenotype is attributable to a defect in the overproduction of interleukin-8 and a deficiency in the production of the angiogenesis inhibitor thrombospondin-1.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7512793      PMCID: PMC1887235     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  39 in total

1.  Neovascularization induced by intraocular xenografts of normal, preneoplastic, and neoplastic mouse mammary tissues.

Authors:  M A Gimbrone; P M Gullino
Journal:  J Natl Cancer Inst       Date:  1976-02       Impact factor: 13.506

Review 2.  Angiogenesis in normal and psoriatic skin.

Authors:  J E Wolf
Journal:  Lab Invest       Date:  1989-08       Impact factor: 5.662

3.  Natural history of psoriasis in 61 twin pairs.

Authors:  E M Farber; M L Nall; W Watson
Journal:  Arch Dermatol       Date:  1974-02

4.  Angiogenesis in psoriasis: therapeutic implications.

Authors:  J Folkman
Journal:  J Invest Dermatol       Date:  1972-07       Impact factor: 8.551

5.  An altered response by psoriatic keratinocytes to gamma interferon.

Authors:  B S Baker; A V Powles; H Valdimarsson; L Fry
Journal:  Scand J Immunol       Date:  1988-12       Impact factor: 3.487

Review 6.  Relation of vascular proliferation to tumor growth.

Authors:  J Folkman; R Cotran
Journal:  Int Rev Exp Pathol       Date:  1976

7.  Angiogenic properties of normal and psoriatic skin associate with epidermis, not dermis.

Authors:  R Malhotra; K S Stenn; L A Fernandez; I M Braverman
Journal:  Lab Invest       Date:  1989-08       Impact factor: 5.662

8.  Modulation of keratinocyte motility. Correlation with production of extracellular matrix molecules in response to growth promoting and antiproliferative factors.

Authors:  B J Nickoloff; R S Mitra; B L Riser; V M Dixit; J Varani
Journal:  Am J Pathol       Date:  1988-09       Impact factor: 4.307

9.  The neutrophil-activating protein (NAP-1) is also chemotactic for T lymphocytes.

Authors:  C G Larsen; A O Anderson; E Appella; J J Oppenheim; K Matsushima
Journal:  Science       Date:  1989-03-17       Impact factor: 47.728

10.  Unique distribution of the extracellular matrix component thrombospondin in the developing mouse embryo.

Authors:  K S O'Shea; V M Dixit
Journal:  J Cell Biol       Date:  1988-12       Impact factor: 10.539

View more
  31 in total

Review 1.  Molecular targeting of angiogenesis for imaging and therapy.

Authors:  Simon S Brack; Ludger M Dinkelborg; Dario Neri
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-08-05       Impact factor: 9.236

Review 2.  Chemokines as mediators of angiogenesis.

Authors:  Borna Mehrad; Michael P Keane; Robert M Strieter
Journal:  Thromb Haemost       Date:  2007-05       Impact factor: 5.249

Review 3.  Angiogenesis in prolactinomas: regulation and relationship with tumour behaviour.

Authors:  N Garcia de la Torre; H E Turner; J A H Wass
Journal:  Pituitary       Date:  2005       Impact factor: 4.107

Review 4.  Angiogenesis drives psoriasis pathogenesis.

Authors:  Regina Heidenreich; Martin Röcken; Kamran Ghoreschi
Journal:  Int J Exp Pathol       Date:  2009-06       Impact factor: 1.925

Review 5.  Cellular adhesion molecules. Newly identified mediators of angiogenesis.

Authors:  P J Polverini
Journal:  Am J Pathol       Date:  1996-04       Impact factor: 4.307

Review 6.  Angiogenesis: possibilities for therapeutic interventions.

Authors:  W Wynendaele; A T van Oosterom; A Pawinski; E A de Bruijn; R A Maes
Journal:  Pharm World Sci       Date:  1998-12

7.  Expression of Angiogenic Factors in Psoriasis Vulgaris.

Authors:  Lakshna Sankar; Dhanalakshmi Arumugam; Sudha Boj; Priyanka Pradeep
Journal:  J Clin Diagn Res       Date:  2017-03-01

8.  Identification of genes responsive to solar simulated UV radiation in human monocyte-derived dendritic cells.

Authors:  Hortensia de la Fuente; Amalia Lamana; María Mittelbrunn; Silvia Perez-Gala; Salvador Gonzalez; Amaro García-Diez; Miguel Vega; Francisco Sanchez-Madrid
Journal:  PLoS One       Date:  2009-08-26       Impact factor: 3.240

9.  Current concepts in the pathogenesis of psoriasis.

Authors:  Rajeev Patrick Das; Arun Kumar Jain; V Ramesh
Journal:  Indian J Dermatol       Date:  2009       Impact factor: 1.494

10.  Therapeutic efficacy and immunological response of CCL5 antagonists in models of contact skin reaction.

Authors:  Miriam Canavese; Fiorella Altruda; Lorenzo Silengo
Journal:  PLoS One       Date:  2010-01-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.